References:
1. Anon: Optimal calcium intake. JAMA 1994; 272:1942-1948.
2. Fleisch H: Bisphosphonates: Pharmacology. Sem Arthritis Rheum 1994; 23:261-262.
3. Gora ML, Seth SK, Bay WK et al: Milk-alkali syndrome associated with use of chlorothiazide and calcium carbonate. Clin Pharm 1989; 8:227-229.
4. Gilman AF, Rall TW, Nies AS et al (eds): Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed. Pergamon Press, New York, NY; 1990.
5. Schneyer CR: Calcium carbonate and reduction of levothyroxine efficacy (letter). JAMA 1998; 33:408-413.
6. Wood RJ & Zheng JJ: High dietary calcium intakes reduce zinc absorption and balance in humans. Am J Clin Nutr 1997; 65:1803-1809.
7. Ivanovitch P, Fellows H & Rich C: The absorption of calcium carbonate. Ann Intern Med 1967; 66:917-923.
8. Dukes MNG: Meyler's side effects of drugs, vol.9. Excerpta Medica, New York, NY; 1980.
9. Shastri RA: Effect of antacids on salicylate kinetics. Int J Clin Pharmacol Ther Toxicol 1985; 23:480-484.
10. Kirch W, Schafer-Korting M, Axthelm T et al: Interaction of atenolol with furosemide and calcium and aluminum salts. Clin Pharmacol Ther 1981; 30:429-435.
11. Wagstaff AJ, Benfield P & Monk JP: Colloidal bismuth subcitrate: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease. Drugs 1988; 36:132-157.
12. Product Information: Vantin(R), cefpodoxime. Pharmacia & Upjohn Company, Kalamazoo, MI, (PI revised 11/2000) reviewed 3/2002.
13. Shiba K, Sakai O, Shimada J et al: Effects of antacids, ferrous sulfate, and ranitidine on absorption of DR-3355 in humans. Antimicrob Agents Chemother 1992; 36:2270-2274.
14. D'Arcy PF & McElnay JC: Drug-antacid interactions: assessment of clinical importance. Drug Intell Clin Pharm 1987; 21:607-617.
15. Carlson JA, Mann HJ & Canafax DM: Effect of pH on disintegration and dissolution of ketoconazole tablets. Am J Hosp Pharm 1983; 40:1334-1336.
16. Product Information: Sporanox(R), itraconazole. Janssen Pharmaceutica Products, L.P., Titusville, New Jersey, (PI revised 2/2002) reviewed 5/2002.
17. Product Information: Levsin(R), hyoscyamine sulfate. Schwarz Pharma, Inc., Milwaukee, WI, 1996.
18. Product Information: Pamine(R), methscopolamine. Upjohn Company, Kalamazoo, MI, 1991.
19. Baluarte HJ, Prebis J, Goldberg M et al: Metabolic alkalosis in an anephric child caused by the combined use of Kayexalate(R) and Basaljel(R). J Pediatr 1978; 92:237.
20. Product Information: Tritec(R), ranitidine bismuth citrate. Glaxo Wellcome Inc., Research Triangle Park, NC, 1999.
21. Product Information: Carafate(R), sucralfate. Hoechst Marion Roussel, Inc., Kansas City, MO, 1996.
22. Shah J, Fratis A, Ellis D et al: Effect of food and antacid on absorption of orally administered ticlopidine hydrochloride. J Clin Pharmacol 1990; 30:733-736.
23. O'Neil-Cutting MA & Crosby WH: The effect of antacids on the absorption of simultaneously ingested iron. JAMA 1986; 255:1468-1470.
24. Heaney RP, Smith KT, Recker RR et al: Meal effects on calcium absorption. Am J Clin Nutr 1989; 49(2):372-376.
25. Kirch W, Schafer-Korting M, Axthelm T, et al: Interaction of atenolol with furosemide and calcium and aluminum salts. Clin Pharmacol Ther 1981; 30:429-435.
26. Mantyla R, Mannisto PT, Vuorela A, et al: Impairment of captopril bioavailability by concomitant food and antacid intake. Int J Clin Pharmacol Ther Toxicol 1984a; 22:626-629.
27. Carlson JA, Mann HJ, & Canafax DM: Effect of pH on disintegration and dissolution of ketoconazole tablets. Am J Hosp Pharm 1983; 40:1334-1336.
28. Van der Meer JWM, Keuning JJ, Scheijgrond HW, et al: The influence of gastric acidity on the bioavailability of ketoconazole. J Antimicrob Chemother 1980; 6:552-554.
29. Marchbanks CR: Drug-drug interactions with fluoroquinolones. Pharmacotherapy 1993; 13:23S-28S.
30. Product Information: Actonel(TM), risedronate. Procter & Gamble Pharmaceuticals, Inc., Cincinnati, OH, 1998.
31. Product Information: Agenerase®, amprenavir. Glaxo Wellcome Inc., Research Triangle Park, NC, 2000.
32. Product Information: Lexiva(TM), fosamprenavir. GlaxoSmithKline, Research Triangle Park, NC, 2003.
33. Baldwin JR, Borin MT, Wang Y, et alBaldwin JR, Borin MT, Wang Y, et al: Effects of food and antacid on bioavailability of the protease inhibitor PNU-140690 in healthy volunteers (abstract), 5th Conf Retrovir Oppor Inf, Chicago, 1998.
34. Product Information: Spectracef(TM), cefditoren pivoxil. TAP Pharmaceuticals, Inc., Lake Forest, Illinois, 2001.
35. Product Information: Boniva(TM), ibandronate sodium tablets. GlaxoSmithKline, Research Triangle Park, NC, 2003.
36. Product Information: Levsin(R), hyoscyamine sulfate. Schwarz Pharma, Inc., Milwaukee, WI, 1996.
37. Delhotal-Landes B, Cournot A, Vermerie N, et al: The effect of food and antacids on lansoprazole absorption and disposition. Eur J Drug Metab Pharmacokinet 1991; Spec No 3:315-320.
38. Dobbs JH, Skoutakis VA, Acchiardo SR, et al: Effects of aluminum hydroxide on the absorption of propranolol. Curr Ther Res 1977; 21:887-892.
39. Ziessman HA: Alkalosis and seizure due to a cation exchange resin and magnesium hydroxide. South Med J 1976; 69:497-499.
40. Fernandez PC & Kovnat PJ: Metabolic acidosis reversed by the combination of magnesium hydroxide and cation exchange resin. N Engl J Med 1972; 286:23.
41. Schroeder ET: Alkalosis resulting from combined administration of a "non-systemic" antacid and a cation-exchange resin. Gastroenterology 1969; 56:868.
42. Product Information: Carafate(R), sucralfate. Hoechst Marion Roussel, Inc., Kansas City, MO, 1996.
43. Shah J, Fratis A, Ellis D, et al: Effect of food and antacid on absorption of orally administered ticlopidine hydrochloride. J Clin Pharmacol 1990; 30:733-736.
44. Product Information: Skelid(R), tiludronate. Sanofi Pharmaceuticals, Inc., New York, NY, 1998.
45. Feldman S & Carlstedt BC: Effects of antacid on absorption of enteric-coated aspirin. JAMA 1974; 227:660.
46. Strickland-Hodge B, Thomas TR, Gould WA, et al: The effects of antacids on enteric-coated salicylate preparations. Rheumatol Rehabil 1976; 15:148-152.
47. Shastri RA: Effect of antacids on salicylate kinetics. Int J Clin Pharmacol Ther Toxicol 1985; 23:480-484.
48. Gaspari F, Vigano G, Tocatelli M, et al: Influence of antacid administrations on aspirin absorption in patients with chronic renal failure on maintenance hemodialysis. Am J Kidney Dis 1988; 11:338-342.
49. Product Information: Dulcolax(R), bisacodyl. Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, 1993.
50. O'Neil-Cutting MA & Crosby WH: The effect of antacids on the absorption of simultaneously ingested iron. JAMA 1986; 255:1468-1470.
51. Wood RJ & Zheng JJ: High dietary calcium intakes reduce zinc absorption and balance in humans. Am J Clin Nutr 1997; 65(6):1803-1809.
52. Gulliford MC, Pover GG, Bicknell EJ, et al: Guar delays intestinal calcium absorption in man. Eur J Clin Nutr 1988; 42(5):451-454.
53. Product Information: Os-Cal(R), calcium carbonate. GlaxoSmithKline, 2004.
54. Product Information: Rocephin(R) injection, ceftriaxone sodium injection. Roche Pharmaceuticals, Nutley, NJ, 2008.
55. Product Information: TARCEVA(R) oral tablets, erlotinib oral tablets. OSI Pharmaceuticals Inc, Melville, NY, 2008.
56. Product Information: PROMACTA(R) oral tablets, eltrombopag oral tablets. Glaxo Smith Kline, Research Triangle Park, NC, 2008.